These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 87342)

  • 21. Inhibition of ellagic acid-activated Hageman factor (factor XII) and Hageman factor fragments by popcorn inhibitor.
    Ratnoff OD; Moneme V
    Proc Soc Exp Biol Med; 1981 Feb; 166(2):297-9. PubMed ID: 7208489
    [No Abstract]   [Full Text] [Related]  

  • 22. [Flavellagic acid influence on blood coagulation and hemostasis disturbed by whole body irradiation].
    Pospísil J; Skala E; Zitko M; Dienstbier Z
    Strahlentherapie; 1983 May; 159(5):299-305. PubMed ID: 6344348
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of N-methyl-N-nitrosourea-induced mutagenicity and DNA methylation by ellagic acid.
    Dixit R; Gold B
    Proc Natl Acad Sci U S A; 1986 Nov; 83(21):8039-43. PubMed ID: 3464940
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Selective inhibition of methylbenzylnitrosamine-induced formation of esophageal O6-methylguanine by dietary ellagic acid in rats.
    Barch DH; Fox CC
    Cancer Res; 1988 Dec; 48(24 Pt 1):7088-92. PubMed ID: 3191485
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Novel Ellagic Acid Derivative from Desbordesia glaucescens.
    DongmoMafodong FL; Tsopmo A; Awouafack MD; Roland TT; Dzoyem JP; Tane P
    Nat Prod Commun; 2015 Oct; 10(10):1709-10. PubMed ID: 26669108
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Activation of intrinsic blood coagulation by ellagic acid: insoluble ellagic acid-metal ion complexes are the activating species.
    Bock PE; Srinivasan KR; Shore JD
    Biochemistry; 1981 Dec; 20(25):7258-66. PubMed ID: 6797471
    [No Abstract]   [Full Text] [Related]  

  • 27. Two ellagic acid glycosides from Gleditsia sinensis Lam. with antifungal activity on Magnaporthe grisea.
    Zhou L; Li D; Jiang W; Qin Z; Zhao S; Qiu M; Wu J
    Nat Prod Res; 2007 Apr; 21(4):303-9. PubMed ID: 17479418
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ellagic acid: a potent naturally occurring inhibitor of benzo[a]pyrene metabolism and its subsequent glucuronidation, sulfation and covalent binding to DNA in cultured BALB/C mouse keratinocytes.
    Mukhtar H; Del Tito BJ; Marcelo CL; Das M; Bickers DR
    Carcinogenesis; 1984 Dec; 5(12):1565-71. PubMed ID: 6333937
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Aldose-reductase- and protein-glycation-inhibitory principles from the whole plant of Duchesnea chrysantha.
    Kim JM; Jang DS; Lee YM; Yoo JL; Kim YS; Kim JH; Kim JS
    Chem Biodivers; 2008 Feb; 5(2):352-6. PubMed ID: 18293434
    [TBL] [Abstract][Full Text] [Related]  

  • 30. DNA damaging activity of ellagic acid derivatives.
    Xu YM; Deng JZ; Ma J; Chen SN; Marshall R; Jones SH; Johnson RK; Hecht SM
    Bioorg Med Chem; 2003 Apr; 11(7):1593-6. PubMed ID: 12628683
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A new ellagic acid glycoside from Paeonia delavayi.
    Wu SH; Chen YW; Yang LY; Li SL; Li ZY
    Fitoterapia; 2008 Sep; 79(6):474-5. PubMed ID: 18534777
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Staining mycobacteria with periodic acid-carbol-pararosanilin: principle and practice of the method.
    Harada K
    Microsc Acta; 1977 May; 79(3):224-36. PubMed ID: 68427
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Two new ellagic acid glycosides from leaves of Diplopanax stachyanthus.
    Yan XH; Guo YW
    J Asian Nat Prod Res; 2004 Dec; 6(4):271-6. PubMed ID: 15621586
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of ellagic acid and hydroxylated flavonoids on the tumorigenicity of benzo[a]pyrene and (+/-)-7 beta, 8 alpha-dihydroxy-9 alpha, 10 alpha-epoxy-7,8,9,10-tetrahydrobenzo[a]pyrene on mouse skin and in the newborn mouse.
    Chang RL; Huang MT; Wood AW; Wong CQ; Newmark HL; Yagi H; Sayer JM; Jerina DM; Conney AH
    Carcinogenesis; 1985 Aug; 6(8):1127-33. PubMed ID: 3926336
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of 3-methylcholanthrene-induced skin tumorigenicity in BALB/c mice by chronic oral feeding of trace amounts of ellagic acid in drinking water.
    Mukhtar H; Das M; Bickers DR
    Cancer Res; 1986 May; 46(5):2262-5. PubMed ID: 3486036
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Some cardiovascular and hematological changes induced in the rat by activation of Hageman factor with ellagic acid.
    Damas J; Remacle-Volon G; Adam A
    Adv Exp Med Biol; 1989; 247A():461-5. PubMed ID: 2603812
    [No Abstract]   [Full Text] [Related]  

  • 37. Contact activation by ellagic acid - the concept of soluble activator disputed.
    Exner T; Rickard KA
    Thromb Res; 1982 Apr; 26(2):83-9. PubMed ID: 7112511
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of benzo(a)pyrene and benzo(a)pyrene-trans-7,8-diol metabolism and DNA binding in mouse lung explants by ellagic acid.
    Dixit R; Teel RW; Daniel FB; Stoner GD
    Cancer Res; 1985 Jul; 45(7):2951-6. PubMed ID: 4039974
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enhancement of pulmonary metastases following the intravenous infusion of a suspension of ellagic acid in traumatized rats.
    Agostino D; Agostino N
    Tumori; 1980 Jun; 66(3):285-93. PubMed ID: 7445109
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mechanism of inhibition of N-methyl-N-nitrosourea-induced mutagenicity and DNA binding by ellagic acid.
    Dixit R; Gold B
    IARC Sci Publ; 1987; (84):197-9. PubMed ID: 2445674
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.